QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

Kintara Therapeutics (KTRA) Short Interest Ratio & Short Volume

$0.10
+0.01 (+10.72%)
(As of 02/26/2024 ET)

Kintara Therapeutics Short Interest Data

Current Short Volume
164,000 shares
Previous Short Volume
407,100 shares
Change Vs. Previous Month
-59.72%
Dollar Volume Sold Short
$23,747.20
Short Interest Ratio / Days to Cover
0.0
Last Record Date
January 31, 2024
Outstanding Shares
39,040,000 shares
Float Size
3,310,000 shares
Short Percent of Float
4.95%
Today's Trading Volume
34,355,772 shares
Average Trading Volume
11,496,977 shares
Today's Volume Vs. Average
299%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Kintara Therapeutics ?

Sign up to receive the latest short interest report for Kintara Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

KTRA Short Interest Over Time

KTRA Days to Cover Over Time

KTRA Percentage of Float Shorted Over Time


Kintara Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/2024164,000 shares $23,747.20 -59.7%5.0%0 $0.14
1/15/2024407,100 shares $56,953.29 +234.8%12.3%0.1 $0.14
12/31/2023121,600 shares $20,623.36 -60.4%3.7%0 $0.17
12/15/2023306,900 shares $60,766.20 -12.8%9.3%0.3 $0.20
11/30/2023352,000 shares $119,680.00 -34.6%10.9%0.5 $0.34
11/15/2023538,500 shares $189,228.90 +541.8%32.3%1.3 $0.35
10/31/202383,900 shares $62,664.91 +126.2%5.0%0.6 $0.75
10/15/202337,100 shares $127,253.00 +152.4%2.2%2.1 $3.43
9/30/202314,700 shares $59,388.00 +53.1%0.9%0.9 $4.04
9/15/20239,600 shares $39,936.00 -66.6%0.6%0.1 $4.16
8/31/202328,700 shares $130,585.00 +38.0%1.8%0.2 $4.55
8/15/202320,800 shares $68,640.00 -23.3%1.2%0.1 $3.30
7/31/202327,100 shares $120,866.00 -46.6%1.6%0.2 $4.46
7/15/202350,700 shares $235,248.00 -9.8%3.1%0.3 $4.64
6/30/202356,200 shares $226,486.00 +200.5%3.4%0.3 $4.03
6/15/202318,700 shares $70,125.00 -26.4%1.1%0.5 $3.75
5/31/202325,400 shares $81,534.00 +75.2%1.5%0.6 $3.21
5/15/202314,500 shares $43,500.00 +12.4%0.9%0.3 $3.00
4/30/202312,900 shares $35,733.00 -41.9%0.8%0.3 $2.77
4/15/202322,200 shares $63,025.80 -12.9%1.4%0.9 $2.84
3/31/202325,500 shares $89,989.50 +390.4%1.6%0.9 $3.53
3/15/20235,200 shares $17,108.00 -85.4%0.3%0.1 $3.29
2/28/202335,600 shares $177,644.00 +65.6%2.2%0.5 $4.99
2/15/202321,500 shares $130,075.00 +9.7%1.3%0.1 $6.05
1/31/202319,600 shares $123,480.00 -14.4%1.2%0.1 $6.30
1/15/202322,900 shares $162,819.00 -42.2%1.5%0.1 $7.11
12/30/202239,600 shares $272,844.00 -56.3%2.7%0.1 $6.89
12/15/202290,600 shares $834,426.00 -75.7%N/A0.2 $9.21
11/30/2022373,400 shares $2.50 million +614.0%N/A1 $6.70
11/15/202252,300 shares $208,154.00 -97.4%N/A0.9 $3.98
10/31/20222,040,000 shares $219,708.00 +196.3%N/A0.9 $0.11
10/15/2022688,400 shares $65,535.68 -16.8%N/A0.2 $0.10
9/30/2022827,000 shares $89,316.00 +2.2%N/A0.3 $0.11
9/15/2022808,900 shares $128,210.65 -11.3%N/A0.3 $0.16
8/31/2022911,400 shares $141,358.14 -31.0%N/A0.3 $0.16
8/15/20221,320,000 shares $245,784.00 +686.7%N/A0.4 $0.19
7/31/2022167,800 shares $31,730.98 -56.4%N/A0 $0.19
7/15/2022384,500 shares $94,548.55 -65.1%N/A0.1 $0.25
6/30/20221,100,000 shares $305,800.00 +158.5%N/A0.3 $0.28
6/15/2022425,500 shares $99,439.35 -35.1%N/A0.1 $0.23













KTRA Short Interest - Frequently Asked Questions

What is Kintara Therapeutics' current short interest?

Short interest is the volume of Kintara Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 164,000 shares of KTRA short. 4.95% of Kintara Therapeutics' shares are currently sold short. Learn More on Kintara Therapeutics' current short interest.

What is a good short interest percentage for Kintara Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.95% of Kintara Therapeutics' floating shares are currently sold short.

Is Kintara Therapeutics' short interest increasing or decreasing?

Kintara Therapeutics saw a decline in short interest during the month of January. As of January 31st, there was short interest totaling 164,000 shares, a decline of 59.7% from the previous total of 407,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Kintara Therapeutics' float size?

Kintara Therapeutics currently has issued a total of 39,040,000 shares. Some of Kintara Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kintara Therapeutics currently has a public float of 3,310,000 shares.

How does Kintara Therapeutics' short interest compare to its competitors?

4.95% of Kintara Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Kintara Therapeutics: Avalo Therapeutics, Inc. (90.33%), Panbela Therapeutics, Inc. (3.66%), SciSparc Ltd. (1.13%), Revelation Biosciences, Inc. (30.78%), Bellerophon Therapeutics, Inc. (0.55%), GRI Bio, Inc. (5.96%), Galmed Pharmaceuticals Ltd. (0.32%), ZyVersa Therapeutics, Inc. (1.54%), Athersys, Inc. (12.51%), Aditxt, Inc. (2.08%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Kintara Therapeutics stock?

Short selling KTRA is an investing strategy that aims to generate trading profit from Kintara Therapeutics as its price is falling. KTRA shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Kintara Therapeutics?

A short squeeze for Kintara Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KTRA, which in turn drives the price of the stock up even further.

How often is Kintara Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KTRA, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:KTRA) was last updated on 2/26/2024 by MarketBeat.com Staff